Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme

<table>Kaplan Meier overall survival for all 31 patients for hypofractionated 4005 centiGray IMRT (blue line) and conventionally fractionated 6000 centiGray IMRT (red line).</table>

Neurology Research International

fig2

Figure 2

Figure 2: Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme 